Skip to content

13F-HR filed by Redmile Group, LLC

Redmile Group, LLC filed this 13F-HR for the quarter ended 2014-06-30, filed 2014-08-15, with 48 holding rows worth $824,504,000.

Accession
0001425738-14-000003
Filed
2014-08-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2014

A holdings report, 48 entries on the cover page, a total value of $824,504,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $824,504,000 with VALUE read as thousands by filing date, 13F file number 028-12776. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ACTAVIS PLCG0083B108SHS176,698$39,412,000thousands by filing date
MEDTRONIC INC585055106COM589,974$37,617,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock8,085,945$36,872,000thousands by filing date
UNIVERSAL HLTH SVCS INC CL B913903100Stock369,603$35,393,000thousands by filing date
HCA Healthcare Inc40412C101COM615,059$34,677,000thousands by filing date
RECEPTOS, INC.756207106COMMON STOCK753,660$32,106,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM723,816$29,973,000thousands by filing date
CHIMERIX INC COM16934W106Stock1,337,150$29,337,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM468,100$29,121,000thousands by filing date
ALLERGAN INC018490102COM170,400$28,835,000thousands by filing date
VALEANT PHARMACEUTICALS INTL91911K102COM227,830$28,734,000thousands by filing date
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock256,053$26,594,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM7,650,268$25,552,000thousands by filing date
TRIVASCULAR TECHNOLOGIES INC89685A102COM1,540,648$22,140,000thousands by filing date
HEALTHWAYS INC422245100COM1,234,771$21,658,000thousands by filing date
KYTHERA BIOPHARMACEUTICALS I501570105COM560,356$21,501,000thousands by filing date
GLOBUS MED INC CL A379577208Stock832,988$19,925,000thousands by filing date
AGILENT TECHNOLOGIES INC COM00846U101Stock346,880$19,925,000thousands by filing date
HEARTWARE INTL INC422368100COM222,926$19,729,000thousands by filing date
Amgen Inc.031162100COM163,254$19,324,000thousands by filing date
Stryker Corporation863667101COM213,918$18,038,000thousands by filing date
NUVASIVE INC670704105COM502,291$17,866,000thousands by filing date
RITEAID CORP767754104COM2,473,855$17,738,000thousands by filing date
NANOSTRING TECHNOLOGIES INC63009R109COM1,133,948$16,953,000thousands by filing date
INTRA-CELLULAR THERAPIES INC46116X101COMMON STOCK979,446$16,513,000thousands by filing date
CASTLIGHT HEALTH INC CL B14862Q100Stock1,164,257$16,463,000thousands by filing date
ACCURAY INC DEL004397105COM1,866,260$16,423,000thousands by filing date
OXFORD IMMUNOTEC GLOBAL PLCG6855A103ORD SHS960,820$16,171,000thousands by filing date
CARDIOVASCULAR SYSTEMS INC141619106COMMON STOCK493,345$15,373,000thousands by filing date
MODEL N INC607525102COM1,360,878$15,038,000thousands by filing date
HMS HLDGS CORP40425J101COM565,593$11,544,000thousands by filing date
STANDARD BIOTOOLS INC34385P108COM392,540$11,541,000thousands by filing date
ORTHOFIX INTL N VN6748L102COM280,642$10,173,000thousands by filing date
INOGEN INC45780L104COM450,500$10,163,000thousands by filing date
ALIGN TECHNOLOGY INC COM016255101Stock175,452$9,832,000thousands by filing date
ACHAOGEN INC004449104COM648,879$9,058,000thousands by filing date
PROTHENA CORP PLC SHSG72800108Stock370,520$8,355,000thousands by filing date
DERMA SCIENCES INC249827502COM PAR $.01600,677$6,944,000thousands by filing date
FLEXION THERAPEUTICS INC33938J106COM504,083$6,795,000thousands by filing date
GERON CORP374163103COM2,051,312$6,585,000thousands by filing date
IGNYTA INC451731103COM577,653$5,251,000thousands by filing date
ISHARES TR464287556ISHARES BIOTECH8,000$2,056,000thousands by filing dateput
MARKET VECTORS PHARM ETF T57060U217ETF6,500$403,000thousands by filing date
ISHARES TR464287556ISHARES BIOTECH1,200$308,000thousands by filing date
INTERCEPT PHARMACEUTICALS IN45845P108COM1,062$251,000thousands by filing date
Boston Scientific Corporation101137107COM10,000$128,000thousands by filing date
SUNESIS PHARMACEUTICALS INC867328601COM NEW10,000$65,000thousands by filing date
OXYGEN BIOTHERAPEUTICS INC69207P308COM PAR $0.000112,500$51,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001425738-14-000003this filing2014-08-15acceptance time not in the bulk data set